In this study, our data first identified that m6A methylation was enriched in ADAMTS9-AS2 using m6A RIP assay in SK-N-SH cells, which could account for ADAMTS9-AS2 differential expression in neuroblastoma cells. Here, ADAMTS9 is linked to neuroblastoma.